This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Gazyva
  • /
  • A Phase III, Multicenter, Open-Label Randomized Tr...
Clinical trial

A Phase III, Multicenter, Open-Label Randomized Trial Comparing the Efficacy of GA101 (RO5072759) in Combination With CHOP (G-CHOP) Versus Rituximab and CHOP (R-CHOP) in Previously Untreated Patients With CD20-Positive Diffuse Large B-Cell Lymphoma (DLBCL

Read time: 2 mins
Last updated:1st Jul 2011
Identifier: NCT01287741
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest